Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation. 2005;112:3569 76. S8.1.2-17. Eddy DM, Adler J, Patterson B, et al. Individualized guidelines: the potential for increasing quality and reducing costs. Ann Intern Med. 2011;154:627 34. S8.1.2-18. Marchant I, Nony P, Cucherat M, et al. The global risk approach should be better applied in French hypertensive patients: a com- parison between simulation and observation studies. PLoS ONE. 2011;6:e17508. S8.1.2-19. Cadilhac DA, Carter R, Thrift AG, et al. Organized blood pressure control programs to prevent stroke in Australia: would they be cost- effective? Stroke. 2012;43:1370 5. S8.1.2-20. Cobiac LJ, Magnus A, Barendregt JJ, et al. Improving the cost- effectiveness of cardiovascular disease prevention in Australia: a modelling study. BMC Public Health. 2012;12:398. S8.1.2-21. Cobiac LJ, Magnus A, Lim S, et al. Which interventions offer best value for money in primary prevention of cardiovascular disease? PLoS ONE. 2012;7:e41842. S8.1.2-22. Karmali KN, Lloyd-Jones DM. Global risk assessment to guide blood pressure management in cardiovascular disease prevention. Hypertension. 2017;69:e2 9. S8.1.2-23. Muntner P, Whelton PK. Using predicted cardiovascular disease risk in conjunction with blood pressure to guide antihypertensive medication treatment. J Am Coll Cardiol. 2017;69:2446 56. S8.1.2-24. Sussman J, Vijan S, Hayward R. Using benefit-based tailored treatment to improve the use of antihypertensive medications. Circulation. 2013;128:2309 17. S8.1.2-25. van der Leeuw J, Ridker PM, van der Graaf Y, et al. Personalized cardiovascular disease prevention by applying individualized pre- diction of treatment effects. Eur Heart J. 2014;35:837 43. S8.1.2-26. Mendis S, Lindholm LH, Mancia G, et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle- income countries. J Hypertens. 2007;25:1578 82. S8.1.2-27. 